Actuate Therapeutics, Inc. (ACTU)
Actuate Therapeutics will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$8.00 - $10.00
Shares Offered
5,555,556
Deal Size
$50.00M
Actuate Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
10
Market Cap
195.91M
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionACTU News
- 5 weeks ago - Actuate Therapeutics Files Registration Statement for Initial Public Offering - GLOBE NEWSWIRE
- 5 weeks ago - Cancer biotech Actuate Therapeutics files for a $50 million IPO - Renaissance Capital
- 5 weeks ago - Actuate Therapeutics IPO Registration Document (S-1) - SEC